Postmarketing Analysis of a Novel, Cordless Ultrasonic Dissector.

Cost-Efficiency of Robotic Surgery.

Total Laparoscopic Hysterectomy (TLH): Where Does the Money Go?

Use of a Novel, Cordless Ultrasonic Dissector for Gynecologic Minimally Invasive Surgical Procedures.

Direct Supply Cost Per Case (DSCPC) of Minimally Invasive Hysterectomy.

Complications of Electromechanical Morcellation Reported in the Manufacturer and User Facility Device Experience (MAUDE) Database.

Role of Minimally Invasive Surgery in Gynecologic Oncology: An Updated Survey of Members of the Society of Gynecologic Oncology.

Phase II study of treatment of advanced ovarian cancer with folate-receptor-targeted therapeutic (vintafolide) and companion SPECT-based imaging agent (99mTc-etarfolatide).

PRECEDENT: a randomized phase II trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD) in combination versus PLD alone in patients with platinum-resistant ovarian cancer.

Folate and folate receptor alpha antagonists mechanism of action in ovarian cancer.